Evaluation of Enzyme Producing K. Pneumoniae and Their Susceptibility to Other Anti-Biotics
Description
Antimicrobial-resistant microbes are now infecting doctors, veterinarians, and other infection control specialists. Material & Method: Collection of samples and isolation of K. pneumoniae, Anti-microbial Susceptibility pattern, Hodge's modified test, Extraction of the bla KPC2 gene's DNA Result & Discussion: More than half of the isolates were resistant to both imipenem and meropenem, with four being just resistant to imipenem. Among the 38 carbapenem resistant isolates, 71% had imipenem MICs above CLSI norms, whereas the remaining 79.9% were intermediately resistant. The MIC50 and MIC90 were 0.19-32, 4 and 16 g/ml, respectively (21.05 percent ). Eight of the isolates had MHT. The blaKPC-2 imipenem MIC is 4-32 g/ml. Neither colistin nor co-trimaxazole resistant BlaKPC-2 isolates. Conclusion: Our institution found blaKPC-2 to be a carbapenem resistant K. pneumoniae pathway. Results demonstrated imipenem disc diffusion can quickly identify these isolates. These illnesses and their associated drug resistance demand infection control and antibiotic stewardship measures.
Files
IJISRT22MAY881.pdf
Files
(204.0 kB)
Name | Size | Download all |
---|---|---|
md5:857b0583ac27d3efebd2621f2ec1e515
|
204.0 kB | Preview Download |